Full-Time

Associate Scientist/Scientist

Nutritional Biology & Safety

Confirmed live in the last 24 hours

Helaina

Helaina

11-50 employees

Produces bioactive dietary supplements from proteins

Food & Agriculture
Healthcare

Compensation Overview

$70k - $115kAnnually

Junior, Mid

New York, NY, USA

Category
Computational Biology
Public Health
Biology Lab & Research
Biology & Biotech
Required Skills
Data Analysis

You match the following Helaina's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • MS with 2+ years of industry experience in Cellular/Molecular Biology or PhD in Cellular/Molecular Biology or related discipline
  • Background knowledge of digestion and gut barrier integrity modeling
  • Skilled in mammalian cell culture and experience with in-vitro/ex-vivo functional assays
  • Strong background in epithelial cell biology
  • Effective communicator, both within a collaborative scientific team and in communicating science to non-technical audiences
Responsibilities
  • Cellular, and molecular assays including cell line (e.g. Caco-2, THP-1), primary cell culture, TEER measurement, fluorescent microscopy, ELISA, Western blot
  • Quantitative assessment of pro-inflammatory, regulatory, and anti-inflammatory levels of cytokines through in-vitro and ex-vivo cell assays
  • Fluorescent imaging of tight junctions and gut barrier integrity
  • Work with Luminex bead based multiplex cytokine level evaluation assays and data analysis
  • Data analytics using software such as PRISM, JMP, and Luminex
  • Handling of ex-vivo samples in a BSL2 aseptic environment
  • Develop/perform simulated digestion modeling assays
  • Develop/perform bioavailability modeling assays
  • Generate detailed SOPs for in-vitro/ex-vivo assays
  • Troubleshoot and optimize equipment when necessary
  • Record and manage data in an electronic lab notebook
  • Prepare technical reports, protocols, and scientific presentations
Desired Qualifications
  • Experience with ADME studies and predictive models of ingredient absorption and bioavailability preferred
  • Start-up or industry experience is a plus

Helaina focuses on advanced nutrition by replicating functional proteins found in the human body to create new nutrients. Its main product, Effera™, is a dietary supplement that mimics Human Lactoferrin, a protein essential for gut health, iron utilization, and immune support. This product allows consumers to access a protein that is naturally present in their bodies, setting Helaina apart from competitors who may not offer such specific bioactive proteins. The goal of Helaina is to enhance vitality and overall health for health-conscious consumers through science-backed nutritional supplements.

Company Size

11-50

Company Stage

Series B

Total Funding

$67.7M

Headquarters

New York City, New York

Founded

2019

Simplify Jobs

Simplify's Take

What believers are saying

  • Helaina raised $45 million in Series B funding to accelerate commercialization of Effera™.
  • The precision fermentation market is projected to grow significantly, benefiting Helaina's technology.
  • Growing consumer interest in functional foods aligns with Helaina's product offerings.

What critics are saying

  • Consumer skepticism towards lab-grown foods could hinder Helaina's market acceptance.
  • The evolving regulatory landscape may delay necessary approvals for Helaina's products.
  • High costs of precision fermentation technology may limit product accessibility.

What makes Helaina unique

  • Helaina uses precision fermentation to replicate human milk proteins, offering unique nutritional benefits.
  • Effera™ is a pioneering product, providing immune and gut health support through lactoferrin.
  • Helaina's technology platform creates bioactive proteins, setting new standards in advanced nutrition.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Disability Insurance

401(k) Company Match

Unlimited Paid Time Off

Paid Parental Leave

Childcare Support

Commuter Benefits

Leadership Development coaching through BetterUp

Growth & Insights and Company News

Headcount

6 month growth

8%

1 year growth

2%

2 year growth

0%
Business Wire
Sep 26th, 2024
Helaina Raises $45 Million in Series B Funding to Accelerate the Commercialization of Human Bioactive Proteins Starting with effera™ Human Lactoferrin

Helaina, the biotechnology company transforming nutrition with human equivalent bioactive proteins, announced today it has raised $45 million in Serie

NutraIngredients USA
Aug 24th, 2023
NutraCast: Helaina charts new territory with breast milk proteins from precision fermentation

The biotech company is writing the safety playbook on novel bioactive proteins and to help with this, Helaina hired a nutritional sciences and regulatory affairs veteran, Ross Peterson, PhD, Helaina's new Director of Regulatory Affairs.

Vegconomist
May 10th, 2023
New York’S Helaina Ready To Commercialize Animal-Free Lactoferrin

After achieving a large-scale manufacturing milestone, bioactive protein company Helaina announces that its first high-value ingredient —animal-free lactoferrin — is ready for commercialization to create consumer products focused on immune health. . Founded in 2019 in New York City, Helaina has raised more than $25 million from leading investors. Helaina is a member of the Precision Fermentation Alliance, a new trade organization formed to promote precision fermentation as a solution for a more resilient and sustainable food system. . A protein found in breast milk, lactoferrin is known for improved nutrient absorption, cognitive support, and antimicrobial defense. Helaina says it improves infant formula and functional foods, such as nutritional bars or supplements

AgFunder News
Apr 4th, 2023
Trendwatching At Future Food-Tech, Part One: From Foodie Chatbots To Lactoferrin From Precision Fermentation

While investor sentiment may have soured on alternative proteins, the recent Future Food-Tech summit in San Francisco attracted a record number of foodtech startups showcasing everything from a chatbot steeped in the latest food trends to lactoferrin from precision fermentation. AFN caught up with a selection of exhibitors at the event, which brought together 1,700 entrepreneurs, investors, and food industry professionals from 52 countries. TasteGPT… ‘like having a personalized, concierge market research assistant that’s always available’

AgFunder News
Mar 8th, 2022
Meet The Female Founder: Helaina’S Laura Katz On Scaling Its Infant Formula Alternative

The US startup's infant formula alternative, made using precision fermentation, offers the same proteins found in human breastmilk. The post Meet the Female Founder: Helainas Laura Katz on scaling its infant formula alternative appeared first on AFN.